home / stock / clrb / clrb news

CLRB News and Press, Cellectar Biosciences Inc. From 06/11/20

Stock Information
Company Name: Cellectar Biosciences Inc.
Stock Symbol: CLRB
Market: NASDAQ
Website: cellectar.com
Menu
CLRB CLRB Quote CLRB Short CLRB News CLRB Articles CLRB Message Board
Get CLRB Alerts

News, Short Squeeze, Breakout and More Instantly...
CLRB - Cellectar to be Granted EU Patent for Phospholipid Ether (PLE) Analogs as Cancer-Targeting Drug Vehicles

FLORHAM PARK, N.J., June 11, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that the European Patent Office...
CLRB - NetworkNewsBreaks - Cellectar Biosciences, Inc. (NASDAQ: CLRB) Secures $20.0M in Underwritten Public Offering

Cellectar Biosciences (NASDAQ: CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, has closed an underwritten public offering for gross proceeds of $20.0 million. According to the update, the offeri...

CLRB - M, OPK among premarket gainers

IZEA Worldwide (NASDAQ: IZEA ) +79% . More news on: IZEA Worldwide, Inc., Second Sight Medical Products, Inc., Immuron Limited, Stocks on the move, , Read more ...

CLRB - Cellectar Bio closes $20M capital raise

Cellectar Biosciences (NASDAQ: CLRB ) has closed its public offerin g of ~14.6M common shares and accompanying Series H warrants to purchase ~8.7M shares at $1.2075. It also issued ~2.8M pre-funded warrants. More news on: Cellectar Biosciences, Inc., Healthcare stocks news, , Stocks on th...
CLRB - Cellectar Biosciences Announces Closing of $20 Million Underwritten Public Offering

FLORHAM PARK, N.J., June 05, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the closing of its previously announced un...

CLRB - APPS, SAVA, PGEN and LPI among midday movers

Gainers: Genius Brands International (NASDAQ: GNUS ) +73% . More news on: Genius Brands International, Inc., Cassava Sciences, Inc., Secoo Holding Limited, Stocks on the move, , Read more ...

CLRB - Cellectar Bio slips 23% after pricing $20M public offering

Cellectar Biosciences (NASDAQ: CLRB ) has priced its public offering for gross proceeds of $20M. More news on: Cellectar Biosciences, Inc., Healthcare stocks news, , Stocks on the move, Read more ...

CLRB - RGA, ARCE among premarket losers

Evofem Biosciences (NASDAQ: EVFM )  -26%  after pricing equity offering. More news on: Evofem Biosciences, Inc., Cellectar Biosciences, Inc., Reinsurance Group of America, Incorporated, Stocks on the move, , Read more ...

CLRB - Cellectar Biosciences Announces Pricing of $20 Million Underwritten Public Offering

FLORHAM PARK, N.J., June 03, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the pricing of an underwritten ...

CLRB - Cellectar Granted SME Status by the European Medicines Agency

FLORHAM PARK, N.J., June 01, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that it has been granted Small ...
Previous 10 Next 10